Modern Etiotropic Therapy of Influenza and ARVI in Adult Patients with Premorbid Pathology

Modern Etiotropic Therapy of Influenza and ARVI in Adult Patients with Premorbid Pathology

An open comparative observational study of the clinical efficacy and safety of riamilovir (Triazavirin™) in patients over age 18 with influenza and acute respiratory viral infections (ARVIs) was conducted during the epidemic seasons of2016-2017 and 2017-2018. Clinical efficacy and safety of riamilov...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. K. Verevshchikov, E. K. Shemyakina, A. U. Sabitov, N. A. Batskalevich
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	influenza acute respiratory viral infection arvi patients with premorbid pathology riamilovir (triazavirin™)
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/96
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Possibilities of Etiotropic Therapy for Influenza and ARVI with Taking into Account the Period of Hospitalization and the Risk of Developing Secondary Complications
by: V. K. Verevshchikov, et al.
Published: (2020-05-01)

New Approaches to Etiotropic Therapy of ARVI Patients with Riamilovir
by: K. V. Zhdanov, et al.
Published: (2024-01-01)

Meta-analysis of randomized controlled clinical trials of Riamilovir eﬃcacy in the etiotropic therapy of acute respiratory viral infection
by: A. U. Sabitov, et al.
Published: (2021-08-01)

Meta-analysis of randomized clinical trials of Riamilovir eﬃcacy in etiotropic therapy of inﬂuenza
by: A. U. Sabitov, et al.
Published: (2021-08-01)

The efficiency and safety of enisamium iodide and umifenoviri in ARVI treatment in real clinical practice
by: V. V. Gordienko, et al.
Published: (2024-01-01)

Prospects for Expanding the Possibilities of Etiotropic Therapy of Acute Respiratory Viral Infections in Primary School Children
by: K. V. Zhdanov, et al.
Published: (2025-06-01)

Molecular Genetic Mechanisms of Influenza A Virus Replication and Mechanisms of Action of Etiotropic Medications
by: M. N. Dunaeva
Published: (2024-06-01)

Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters
by: S. V. Chepur, et al.
Published: (2021-10-01)

Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow
by: T. S. Saltykova, et al.
Published: (2020-04-01)

The Use of Plant Origin Remedies in Children with ARVI
by: O. V. Shamsheva
Published: (2018-12-01)

Pharmacological and Epidemiological Study of the Course of Influenza and Other ARVI in the Season 2010/11 in Children under the Age of 18
by: V. F. Uchaikin, et al.
Published: (2016-04-01)

Estimation of Epidemiological Effectiveness of the Program of Pharmaceutical Prevention of Influenza and ARVI «Antigripp» in Organized Children's Groups
by: I. B. Yakovlev, et al.
Published: (2016-04-01)

NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
by: I. V. Nikolaeva
Published: (2015-08-01)

Optimization of the therapy of ARVI and influenza in outpatient practice
by: D. S. Sukhanov, et al.
Published: (2024-04-01)

PREMORBIDITY IN ACUTE INFLAMMATION OF THE MAXILLOFACIAL AREA IN CHILDREN
by: P.І. Tkachenko, et al.
Published: (2020-09-01)

The Spread of RS-virus Infection and other ARVI not Influenza Etiology in Children and Adults in the Regions of Russia from 2014 to 2016
by: L. S. Karpova, et al.
Published: (2018-04-01)

Epidemiological characteristics of acute respiratory viral infection and influenza in Russian Federation and Moscow
by: T. S. Saltykova, et al.
Published: (2019-05-01)

The Antiviral Activity Study of Complex Drug with Aminocapronic Acid for Prevention of Influenza and ARVI
by: A. S. Karpova, et al.
Published: (2019-05-01)

The Role of Premorbid Background in Tanatogenesis of Acute Poisonings with Psychoactive Drugs in Gerontological Patients
by: K. K. Ilyashenko, et al.
Published: (2018-11-01)

ACTUAL METHODS’ OF DIAGNOSIS AND TREATMENT ARVI
by: A. N. Kupchenko, et al.
Published: (2016-03-01)

CLINICAL AND ETIOLOGICAL CHARACTERISTICS OF ACUTE RESPIRATORY VIRAL INFECTIONS IN HOSPITALIZED CHILDREN OF THE CITY OF KHABAROVSK IN EPIDEMIC SEASONS 2014—2017
by: R. A. Gladkikh, et al.
Published: (2018-07-01)

Detection of Anti-viral Drug Riamilovir and Herbicides in Aqueous Media by Using Pyrene-based Fluorescent Chemosensors
by: I. S. Kovalev, et al.
Published: (2021-05-01)

Assessment of the Costs Associated with Outpatient and Inpatient Treatment of ARVI and Influenza and its Complications
by: Z. Sh. Nurmatov
Published: (2015-10-01)

Premorbid factors of early post-stroke cognitive impairment
by: A. А. Grishina, et al.
Published: (2022-10-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives
by: Konstantin V. Kozlov, et al.
Published: (2024-12-01)

Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021
by: E. I. Burtseva, et al.
Published: (2022-09-01)

Comparative Effectiveness of Riamilovir and Umifenovir for Treating Influenza
by: A. F. Popov, et al.
Published: (2021-06-01)

Influence of comorbid pathology and age on the duration of inpatient treatment in adult patients with respiratory synctyl virus infection
by: I. I. Tokin, et al.
Published: (2025-06-01)

Comparative Characteristics of Morbidity with Temporary Disability due to Influenza and AURI in the Russian Federation and Moscow in Recent Years
by: B. A. Zhigarlovsky
Published: (2019-06-01)

Comparative clinical and economic evaluation of two alternative antiviral therapy regimens for influenza patients
by: I. I. Tokin, et al.
Published: (2018-07-01)

Demographic, Premorbid, and Clinical Characteristics of Schizophrenia Spectrum Patients with High and Low Polygenic Liability to the Disorder
by: Margarita Alfimova, et al.
Published: (2025-02-01)

ТЕРАПИЯ ОРВИ И ГРИППА ИММУНОМОДУЛИРУЮЩИМ ПРЕПАРАТОМ ДЕРИНАТ
by: О. Ю. Филатов, et al.
Published: (2012-04-01)

The Eﬃcacy and Safety of Riamilovir in the Treatment of Patients with COVID-19
by: А. U. Sabitov, et al.
Published: (2021-05-01)

Parameters of the Influenza Epidemic in Russia in the 2019-2020 Season
by: L. S. Karpova, et al.
Published: (2021-01-01)

Toxicity of Triazavirin, a Novel Russian Antiinfluenza Chemotherapeutic
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Premorbid and current intellectual performance reflects different backgrounds in patients with Parkinson's disease
by: Hidetomo Murakami, et al.
Published: (2025-03-01)

Theory of mind variability in schizophrenia: A neurodevelopmental perspective through neurological soft signs and premorbid adjustment
by: M. Giralt-López, et al.
Published: (2025-12-01)

ESTIMATION OF MOLECULES OF AVERAGE AND LOW MASS, PEPTIDES OF SERUM IN INFANTS WITH PNEUMONIA AND ARVI
by: S. S. Shevchenko, et al.
Published: (2015-09-01)

ARVI treatment in children
by: L. V. Nikitina
Published: (2021-06-01)